导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 3.70% | 47/60 |
| 近一周 | -0.07% | 32/60 |
| 近一月 | 0.07% | 15/60 |
| 近一季 | 0.04% | 26/60 |
| 近半年 | 1.48% | 43/60 |
| 近一年 | 3.33% | 45/60 |
| 近两年 | 4.55% | 48/58 |
| 近三年 | 4.84% | 41/53 |
| 成立以来 | 7.18% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
2.40% 16/64 |
0.47% 52/64 |
0.62% 52/60 |
- - |
| 2024 | 0.73% 47/64 |
-0.59% 41/59 |
0.76% 24/62 |
1.09% 51/62 |
-0.52% 24/64 |
| 2023 | -0.27% 45/68 |
0.06% 54/63 |
-0.44% 35/63 |
-2.01% 30/66 |
2.16% 45/68 |
| 2022 | 2.45% 14/63 |
-4.84% 36/66 |
4.50% 7/67 |
4.17% 9/63 |
-1.10% 48/63 |
| 2021 | -8.57% 51/67 |
-0.83% 232/312 |
-0.95% 254/328 |
-1.46% 142/358 |
-5.54% 50/68 |
| 2020 | -1.88% 34/68 |
-4.14% 62/280 |
5.95% 209/295 |
-2.15% 219/299 |
-1.28% 264/305 |
| 2019 | 10.93% 15/55 |
4.10% 196/258 |
2.62% 98/267 |
3.21% 63/253 |
0.61% 220/266 |
| 2018 | 3.24% 7/45 |
- - |
3.34% 42/227 |
3.79% 91/225 |
0.03% 34/241 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 国投瑞银白银期货(LOF)A | 1.7164 | 48.92% |
| 国投瑞银白银期货(LOF)C | 1.7017 | 48.76% |
| 泰信现代服务业混合 | 2.1670 | 38.91% |
| 创金合信全球医药生物股票发起(QDII)C | 1.7789 | 37.65% |
| 泰信发展主题混合 | 1.8890 | 37.48% |
| 永赢先锋半导体智选混合发起A | 1.2881 | 28.89% |
| 永赢先锋半导体智选混合发起C | 1.2863 | 28.72% |
| 易方达标普生物科技美元汇C | 0.2399 | 28.01% |
| 嘉实资源精选股票A | 4.7401 | 21.68% |
| 华商致远回报混合C | 1.6720 | 21.39% |
| 汇添富美元债债券(QDII)人民币A VS. () |